COSA 2014* , ,
Presentations this author is a contributor to:
Assessment of surgical downstaging in an open-label Phase 2 trial of denosumab in patients with Giant Cell Tumour of Bone (#411)
3:00 PM
Paul D Stalley
Poster discussion 2
Rapid fluorodeoxyglucose-positron emission tomography (FDG-PET) response to denosumab treatment in patients with giant cell tumour of bone (GCTB): results from two phase 2 trials (#416)
3:00 PM
David Thomas
Poster discussion 2